Candel Therapeutics (CADL) Other Working Capital Changes (2020 - 2025)
Candel Therapeutics (CADL) reported Other Working Capital Changes of -$105000.0 for Q4 2025, up 21.64% on a YoY basis from -$86319.0 in Q4 2024, and up 18.6% sequentially from -$129000.0 in Q3 2025.
Candel Therapeutics (CADL) Other Working Capital Changes (2020 - 2025) Analysis & Trends
Candel Therapeutics (CADL) has 6 years of Other Working Capital Changes data on file, last reported at -$105000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Working Capital Changes rose 21.64% year-over-year to -$105000.0; the trailing twelve-month figure through Dec 2025 stood at -$509000.0 (up 0.78% YoY), and the FY2025 full-year result was -$509000.0, up 0.78% from the prior year.
- Other Working Capital Changes improved to -$105000.0 in Q4 2025, from -$129000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $2.5 million in Q3 2021 to a low of -$1.2 million in Q4 2025.
- A 5-year average of $118250.0 and a median of -$17500.0 in 2024 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes slumped 506.25% in 2022 and jumped 261.54% in 2023, its largest moves.
- Tracing CADL's Other Working Capital Changes over 5 years: stood at -$31000.0 in 2021, then plunged by 293.55% to -$122000.0 in 2022, then sank by 250.82% to -$428000.0 in 2023, then surged by 68.69% to -$134000.0 in 2024, then rose by 21.64% to -$105000.0 in 2025.
- Business Quant data shows CADL's Other Working Capital Changes at -$105000.0 in Q4 2025, -$129000.0 in Q3 2025, and -$139000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Candel Therapeutics | 542.51 Mn | 542.51 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -105,000.00 |
| Dec 31, 2025 | -105,000.00 |
| Dec 31, 2025 | -105,000.00 |
| Sep 30, 2025 | -129,000.00 |
| Sep 30, 2025 | -129,000.00 |
| Sep 30, 2025 | -129,000.00 |
| Jun 30, 2025 | -139,000.00 |
| Jun 30, 2025 | -139,000.00 |
| Jun 30, 2025 | -139,000.00 |
| Mar 31, 2025 | -136,000.00 |
| Mar 31, 2025 | -136,000.00 |
| Mar 31, 2025 | -136,000.00 |
| Dec 31, 2024 | -134,000.00 |
| Dec 31, 2024 | -134,000.00 |
| Dec 31, 2024 | -134,000.00 |
| Sep 30, 2024 | -130,000.00 |
| Sep 30, 2024 | -130,000.00 |
| Sep 30, 2024 | -130,000.00 |
| Jun 30, 2024 | -126,000.00 |
| Jun 30, 2024 | -126,000.00 |